HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles
Authors:
- Ekaterina S. KuliginaEKEkaterina S. Kuligina
- Alexandr A. RomankoARAlexandr A. Romanko
- Tatjana JankevicTJTatjana Jankevic
- Aleksandr S. MartianovAMAleksandr S. Martianov
- Alexandr O. IvantsovAIAlexandr O. Ivantsov
- Tatyana N. SokolovaTSTatyana N. Sokolova
- Dmitry TrofimovDTDmitry Trofimov
- Aniruddh KashyapAKAniruddh Kashyap
- Cezary CybulskiCCCezary Cybulski
- Jan LubińskiJLJan Lubiński
- Evgeny N. ImyanitovEIEvgeny N. Imyanitov
- 21 September 2024
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 209 (2) , 341-354
Abstract
Purpose Female carriers of germline BRCA1 mutations almost invariably develop breast cancer (BC); however, the age at onset is a subject of variation. We hypothesized that the age-related penetrance of BRCA1 mutations may depend on inherited variability in the host immune system. Methods Next-generation sequencing was utilized for genotyping of HLA class I/II genes (HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5) in patients with BRCA1-associated BC with early (< / = 38 years, n = 215) and late (> / = 58 years, n = 108) age at onset. Results HLA-DQB1*06:03P prevalence was higher in the late-onset group due to the excess of allele carriers [25/108 (23.1%) vs. 22/215 (10.2%); OR 2.96, p < 0.001]. For all HLA-I loci, there was a trend toward an increase in the number of homozygotes in the early-onset group. This trend reached statistical significance for the HLA-A [14.4% vs. 6.5%, p = 0.037; OR 2.4, p = 0.042]. The frequencies of HLA-DPB1, HLA-DQB1, and HLA-DRB1/3/4/5 homozygous genotypes did not differ between young-onset and late-onset patients. The maximum degree of homozygosity detected in this study was 6 out of 7 HLA class I/II loci; all six carriers of these genotypes were diagnosed with BC at the age < / = 38 years [OR 6.97, p = 0.187]. Conclusion HLA polymorphism may play a role in modifying the penetrance of BRCA1 pathogenic variants. Certain HLA alleles or HLA homozygosity may modify the risk of BC in BRCA1 carriers.Keywords
All Related Versions
Funding Information
- Russian Science Foundation (#22-15-00278)
This publication has 46 references indexed in Scilit:
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACEJNCI: Journal of the National Cancer Institute, 2013
- Association between HLA‐DQA1, HLA‐DQB1 and oral cancerThe Kaohsiung Journal of Medical Sciences, 2011
- COMPUTATIONAL PREDICTION OF MHC II-ANTIGEN BINDING SUPPORTS DIVERGENT ALLELE ADVANTAGE AND EXPLAINS TRANS-SPECIES POLYMORPHISMEvolution, 2011
- MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2Genes & Immunity, 2008
- Analysis of HLA class I–II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancerTissue Antigens, 2007
- Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, CanadaJNCI: Journal of the National Cancer Institute, 2006
- Regulation of MHC class II gene expression by the class II transactivatorNature Reviews Immunology, 2005
- HLA-DQB1 and cervical cancer in Venezuelan womenGynecologic Oncology, 2005
- The DNA sequence and analysis of human chromosome 6Nature, 2003
- Performing the Exact Test of Hardy-Weinberg Proportion for Multiple Alleles1992